Alveo Closes $38 Million in Series A Funding

“We are pleased to have attracted a strong syndicate of investors to Alveo,” said Ron Chiarello PhD, Alveo’s founder and chief executive officer. “This funding accelerates our vision to provide lifesaving medical information to those who need it at the most critical times — with technology that is flexible, inexpensive, and accessible worldwide. Our team is focused on delivering the global health benefits that are now within reach.”

The offering proceeds will be used to advance the optimization and commercialization of Alveo’s diagnostic platform.